Secular trends in smoking in relation to prevalent and incident smoking-related disease: A prospective populationbased study

Tobacco Induced Diseases

Volumn 17, Issue October, 2019, Pages

  Tonnesen, Philip ^a   Marott, Jacob L ^b   Nordestgaard, Borge ^b   Egil Bojesen, Stig ^b   Lange, Peter ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Asthma; Chronic obstructive pulmonary disease (COPD); Incidence of smoking; Prevalence of tobacco smoking; Special populations

Indexed keywords

ADULT; AGE; ARTICLE; ASTHMA; BEHAVIOR CHANGE; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DENMARK; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENOTYPE; HEART FAILURE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING CESSATION; SMOKING HABIT; TREND STUDY;

EID: 85076500014     PISSN: None     EISSN: 16179625     Source Type: Journal    
DOI: 10.18332/tid/112459     Document Type: Article

References (19)

1. Jha P, Peto R. Global effects of smoking, of quitting, and of taxing tobacco. N Engl J Med. 2014;370:60-68. doi:10.1056/nejmra1308383
2. Chalmers GW, Macleod KJ, Little SA, Thomson LJ, McSharry CP, Thomson NC. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax. 2002;57:226-230. doi:10.1136/thorax.57.3.226
3. Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142:233-239. doi:10.7326/0003-4819-142-4-200502150-00005
4. Engelmann J, Manuwald U, Rubach C, et al. Determinants of mortality in patients with type 2 diabetes: a review. Rev Endocr Metab Disord. 2016;17:129-137. doi:10.1007/s11154-016-9349-0
5. Cea Soriano L, Johansson S, Stefansson B, Rodriguez LA. Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors. Cardiovasc Diabetol. 2015;14:38. doi:10.1186/s12933-015-0204-5
6. Kwak MJ, Kim J, Bhise V, Chung TH, Petitto GS. National Trends in Smoking Cessation Medication Prescriptions for Smokers With Chronic Obstructive Pulmonary Disease in the United States, 2007-2012. J Prev Med Public Health. 2018;51(5):257-262. doi:10.3961/jpmph.18.119
7. Tottenborg SS, Clark AJ, Thomsen RW, Johnsen SP, Lange P. Socioeconomic inequality in the use of prescription medications for smoking cessation among patients with COPD: a nationwide study. Int J Chron Obstruct Pulmon Dis. 2018;13:1775-1781. doi:10.2147/copd.s158954
8. Stegberg M, Hasselgren M, Montgomery S, et al. Changes in smoking prevalence and cessation support, and factors associated with success of smoking cessation in Swedish patients with asthma and COPD. Eur Clin Respir J. 2018;5(1):1421389. doi:10.1080/20018525.2017.1421389
9. Holm M, Schioler L, Andersson E, et al. Predictors of smoking cessation: A longitudinal study in a large cohort of smokers. Respir Med. 2017;132:164-169. doi:10.1016/j.rmed.2017.10.013
10. Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med. 2012;186(10):975-981. doi:10.1164/rccm.201207-1299oc
11. Colak Y, Afzal S, Nordestgaard BG, Vestbo J, Lange P. Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study. Lancet Respir Med. 2017;5:426-434. doi:10.1016/s2213-2600(17)30119-4
12. Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 2008;452:638-642. doi:10.1038/nature06846
13. Thorgeirsson TE, Gudbjartsson DF, Surakka I, et al. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet. 2010;42:448-453. doi:10.1038/ng.573
14. Kaur-Knudsen D, Nordestgaard BG, Bojesen SE. CHRNA3 genotype, nicotine dependence, lung function and disease in the general population. Eur Respir J. 2012;40:1538-1544. doi:10.1183/09031936.00176811
15. Wor ld Heal th Organi zat ion. ICD-10 onl ine versions. https://www.who.int/classifications/icd/icdonlineversions/en/. Accessed June 26, 2019.
16. Tashkin DP, Rennard S, Hays JT, Ma W, Lawrence D, Lee TC. Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. Chest. 2011;139(3):591-599. doi:10.1378/chest.10-0865
17. Danielsen SE, Lochen ML, Medbo A, Linea M, Vold, Melbye H. A new diagnosis of asthma or COPD is linked to smoking cessation-the Tromso study. Int J Chron Obstruct Pulmon Dis. 2016;11:1453-1458. doi:10.2147/copd.s108046
18. Newsom JT, Huguet N, McCarthy MJ, et al. Health behavior change following chronic illness in middle and later life. J Gerontol B Psychol Sci Soc Sci. 2012;67:279-288. doi:10.1093/geronb/gbr103
19. Dawood N, Vaccarino V, Reid KJ, et al. Predictors of smoking cessation after a myocardial infarction: the role of institutional smoking cessation programs in improving success. Arch Intern Med. 2008;168:1961-1967. doi:10.1001/archinte.168.18.1961